Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can what you eat ease menopausal brain fog? new study investigates

NCT ID NCT07648667

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will look at how diet relates to memory and concentration problems (brain fog) in perimenopause. Researchers will ask 60 women aged 40-55 to complete computer-based mental tasks and answer questionnaires about their symptoms and nutrition. The goal is to find which tasks best capture perimenopause-related changes and to understand the role of diet in these cognitive symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify which mental tests best measure brain fog in perimenopause and reveal how nutrition might affect thinking and memory.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply to all women. It is designed to gather information, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Perimenopausal women aged 40-55 years who report being severely affected by cognitive symptoms/brain fog and those who do not report being severely affected.

Ages

40 to 55 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 40-55 years * Self-assess as healthy * Experienced troublesome perimenopause symptoms for at least the past 6 months (as assessed by the Menopause Rating Scale) * Not post-menopause (defined as 12 months with no periods) * Non-smoker (including vaping) * Not lactating or pregnant (or seeking pregnancy) * Oral contraception and hormone replacement therapy allowed if taken for at least 3 months prior * Cognitive symptoms/brain fog are not required for participation Exclusion Criteria: * Post-menopause (12 months with no periods) * Medically induced perimenopause symptoms * Antidepressant/antianxiety medication or other medication likely to affect cognition in the past 6 months * Receiving gender-affirming hormone therapy * Nutritional supplementation (apart from vitamin D) within the last month (more than 3 consecutive days or 4 total)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive function in perimenopause are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Mental Fatigue

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • School of Psychology, Northumbria University

    Newcastle upon Tyne, Tyne & Wear, NE1 8ST, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.